🇺🇸 FDA
Patent

US 6734014

Methods and compositions for transforming dendritic cells and activating T cells

expired A61KA61K40/19A61K40/24

Quick answer

US patent 6734014 (Methods and compositions for transforming dendritic cells and activating T cells) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 11 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K40/19, A61K40/24, A61K40/4245, A61K40/4272